Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > this is done

<< Previous

Bullboard Posts

Next >>

Comment by Captainblkon Mar 01, 2021 5:20pm

162 Views

Post# 32691003

RE:RE:RE:RE:RE:RE:RE:this is done

Rustyboyjangles wrote: Is anyone down to take some extra funds and drive this baby up tomorrow? Myself and a few others in my group really want to show these shorties what's up .... we are investing quite a lot of money to help drive this thing up because we have even more at risk then what we are playing with tomorrow but if we all buy more and drive this stock up!!! No one will be able to drop this thing if non of us sell any shares

I dont know much about that..... but I know I just like this stock.

while I know they are different industries mostly, CBDT went from 0.7 to 2.28 in 3 months.... unique for sure, but even capturing 25% of those gains would be serious business.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing